drugset / Trial / NCT00452543

Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism

NCT00452543

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a study about treatment for people who suffer from both major depression and alcohol abuse or dependence. The study will examine whether the addition of acamprosate to escitalopram and behavioral interventions will improve outcomes for this population.

Timeline

Start
2007-03
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Acamprosate Small molecule 333 mg Oral
Background Escitalopram Small molecule 30 mg Oral